Skip to main content

Equities Lead Investor Sentiment – Research on PositiveID, Elite Pharmaceuticals, Century Communities and iShares PHLX Semiconductor

NEW YORK, NY / ACCESSWIRE / November 5, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: PositiveID Corp (OTC: PSID),Elite Pharmaceuticals Inc (OTC: ELTP), Century Communities Inc (NYSE: CCS) and iShares PHLX Semiconductor ETF (NASDAQ: SOXX). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

PSID Research Package: http://www.traders-choice.com/pdf?s=PSID

ELTP Research Package: http://www.traders-choice.com/pdf?s=ELTP

CCS Research Package: http://www.traders-choice.com/pdf?s=CCS

SOXX Research Package: http://www.traders-choice.com/pdf?s=SOXX

============

Highlights from today's reports include:

On Wednesday, November 04, 2015, NASDAQ ended at 5,142.48 down 0.05%, Dow Jones declined 0.28%, to finish the day at 17,867.58, and the S&P closed at 2,102.31, down 0.35%.

- PositiveID Corp's stock edged higher by 7.27% to close Wednesday's session at USD 0.0310. The company's shares oscillated between USD 0.0277 and USD 0.0318. The stock recorded a trading volume of 4.14 million shares, which was below its 50-day daily average volume of 4.36 million shares and below its 52-week average volume of 4.30 million shares. Over the last three days, PositiveID Corp's shares have declined by 3.13%. However, over the last three months, the stock has gained 7.27% and in the past six months, the shares have picked up 69.40%. On a compounded total return basis, the stock has returned 22.53% in the past one month. The company has an Enterprise Value of USD 13.64 million with Enterprise Value to Revenue ratio of 19.30. Furthermore, the stock is trading at a price to sales ratio of 14.31 with an RSI (Relative Strength Index) of 64.81.

- The stock of Elite Pharmaceuticals Inc gained 23.87% to close Wednesday's session at USD 0.3871. The shares of the company moved in the range of USD 0.3020 and USD 0.3980. A trading volume of 8.35 million shares was recorded, which was greater than its 150-day daily average volume of 1.02 million shares and above its 52-week average volume of 1.25 million shares. The stock is currently trading 63% and 77% above its 50-day and 200-day moving averages, respectively. Over the last five days, Elite Pharmaceuticals Inc's shares have advanced 34.41%. Additionally, over the last six months, the shares have registered a gain of 72.04%. The stock has returned 75.95% in the past one month, and 69.04% in the last three months, on a compounded total return basis. Further, the stock is trading at a price to earnings ratio of 9.77. This compares to a historical PE ratio of 6.42.

- Century Communities Inc's stock increased by 2.30% to close Wednesday's session at USD 19.15. The company's shares fluctuated in the range of USD 18.55 and USD 19.24. A total of 0.07 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.13 million shares and was below its 52-week average volume of 0.12 million shares. The company has an Enterprise Value of USD 656.28 million with EV/Revenue ratio of 1.14 and EV/EBITDA ratio of 12.95. Furthermore, the company is trading at a price to earnings ratio of 14.84. This compares to a historical PE ratio of 16.84. Over the last three days Century Communities Inc's shares have advanced 0.37%. However, over the last three months, the stock has lost 0.26%. Additionally, the stock has an RSI (Relative Strength Index) of 67.39 and it is trading slightly below its 50-day and 200-day moving averages of USD 20.40 and USD 20.46, respectively.

- iShares PHLX Semiconductor's ETF added 0.29% to close Wednesday's session at USD 91.06. The units oscillated between USD 90.42 and USD 91.27. The fund recorded a trading volume of 0.49 million units, which was below its 50-day daily average volume of 0.70 million units and above its 52-week average volume of 0.42 million units. Over the last five days, iShares PHLX Semiconductor ETF has gained a momentum of 8.70%. In addition, over the last three months, the fund has gained 4.21%. The fund has returned 10.82% in the past one month, and 5.10% in the past one year, on a compounded total return basis. The fund is currently trading above its 50-day and 200-day moving averages of USD 91.05 and USD 90.93, respectively. Additionally, iShares PHLX Semiconductor ETF has a current dividend yield of 1.07%. Further, the fund has an RSI of 47.83.

--

About Trader's Choice:

Trader's Choice ("TC') produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.